🔗 Permalink

Assignee profile:

JENRIN DISCOVERY

City:

Wilmington, Delaware

Country:

United States

Published Applications:

Last publication date:

2014-11-06

Patent Grants:

Last grant date:

2015-09-15

Top Inventors for applications by JENRIN DISCOVERY

These are the the leading inventors for applications assigned to JENRIN DISCOVERY:

Robert J. Chorvat 18 West Chester, PA United States
John F. McElroy 17 Wilmington, DE United States
John Francis McElroy 3 Wilmington, DE United States
Robert J. Chorvat 2 Chadds Ford, PA United States

Parthasarathi Rajagopalan 2 Chennai, India
Rajagopalan Parthasarathi 1 Chennai, India
David Nugiel 1 Cherry Hill, NJ United States

Recent patent applications by JENRIN DISCOVERY

JENRIN DISCOVERY based in Wilmington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-11-06 ✅ Patent 9,133,127 granted on 2015-09-15

US20140329875A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

#2 | 2013-01-03

US20130005784A1

Chemistry; metallurgy

CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

#3 | 2012-10-18 ✅ Patent 8,853,252 granted on 2014-10-07

US20120264797A1

Human necessities

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#4 | 2012-10-18 ✅ Patent 8,648,072 granted on 2014-02-11

US20120264754A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#5 | 2012-07-12 ✅ Patent 8,716,265 granted on 2014-05-06

US20120178717A1

Chemistry; metallurgy

4-quinolinemethanols as anti-malarial agents

#6 | 2012-06-21 ✅ Patent 8,580,768 granted on 2013-11-12

US20120157414A1

Chemistry; metallurgy

Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#7 | 2012-01-19

US20120015909A1

Chemistry; metallurgy

MAO-B INHIBITORS USEFUL FOR TREATING OBESITY

#8 | 2011-10-20 ✅ Patent 8,217,038 granted on 2012-07-10

US20110257178A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#9 | 2011-06-30 ✅ Patent 8,334,282 granted on 2012-12-18

US20110160179A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#10 | 2010-07-01 ✅ Patent 8,541,475 granted on 2013-09-24

US20100168068A1

Chemistry; metallurgy

MAO-B inhibitors useful for treating obesity

#11 | 2010-06-17 ✅ Patent 8,088,809 granted on 2012-01-03

US20100152260A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#12 | 2010-04-29 ✅ Patent 8,138,216 granted on 2012-03-20

US20100105751A1

Human necessities

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#13 | 2010-02-18 ✅ Patent 8,252,791 granted on 2012-08-28

US20100041650A1

Human necessities

Purine compounds as cannabinoid receptor blockers

#14 | 2009-11-19 ✅ Patent 8,236,821 granted on 2012-08-07

US20090286758A1

Chemistry; metallurgy

Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#15 | 2009-08-06 ✅ Patent 7,759,335 granted on 2010-07-20

US20090197857A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#16 | 2009-05-07 ✅ Patent 7,655,685 granted on 2010-02-02

US20090118345A1

Human necessities

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#17 | 2009-03-12 ✅ Patent 8,133,904 granted on 2012-03-13

US20090069329A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#18 | 2009-02-05 ✅ Patent 7,666,889 granted on 2010-02-23

US20090036511A1

Chemistry; metallurgy

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#19 | 2008-11-20 ✅ Patent 8,088,926 granted on 2012-01-03

US20080287505A1

Chemistry; metallurgy

Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#20 | 2007-01-04 ✅ Patent 7,956,220 granted on 2011-06-07

US20070004683A1

Chemistry; metallurgy

MAO-B inhibitors useful for treating obesity

Also check out Jenrin Discovery's (Wilmington, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

1967 ⎘